NCT06311149

Brief Summary

The Multitude is a registry of patients who receive commercially available CIEDs that remotely communicate through the LATITUDE monitoring system and transfer data to a central database. The registry is designed to constitute a shared environment for the collection, management, analysis and reporting of clinical and diagnostic data, adopted by a network of European scientifically-motivated physicians who use rhythm management diagnostic and therapeutic solutions from Boston Scientific in their clinical practice. The Multitude study will facilitate the sharing of scientific proposals within a large network of researchers, and it will allow researchers to record the experience with medical devices throughout the device and patient lifecycle.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20,000

participants targeted

Target at P75+ for all trials

Timeline
215mo left

Started Dec 2023

Longer than P75 for all trials

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress12%
Dec 2023Dec 2043

Study Start

First participant enrolled

December 1, 2023

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 7, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 15, 2024

Completed
19.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2043

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2043

Last Updated

August 12, 2024

Status Verified

December 1, 2023

Enrollment Period

20.1 years

First QC Date

March 7, 2024

Last Update Submit

August 8, 2024

Conditions

Keywords

Cardiac implantable electrical deviceImplantable cardioverter defibrillatorPacemakerCardiac resynchronization therapySubcutaneous defibrillatorImplantable cardiac monitorRemote monitoringLatitude monitoring system

Outcome Measures

Primary Outcomes (1)

  • Mortality

    Mortality

    10 years

Secondary Outcomes (3)

  • Hospitalization

    10 years

  • Device therapy

    10 years

  • Device-related complications

    10 years

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The subjects will be recruited from the general patient population of the participating centers who are * receiving diagnosis or treatment using a device monitored through the LATITUDE monitoring system and * fulfilling all inclusion criteria and none of the exclusion criteria.

You may qualify if:

  • Subject is willing and capable of providing informed consent to collect/store/process personal health information by the sponsor or such consent is provided by a legally designated representative, if required by local law or regulation.
  • Subject is:
  • prospectively scheduled for receiving a device monitored through the LATITUDE monitoring system
  • retrospectively enrolled after having received a device monitored through the LATITUDE monitoring system

You may not qualify if:

  • Subject foreseen not to be followed at the enrolling center for at least 1 year after having received the device.
  • Subject is receiving a device that is not approved for commercial use at the time of procedure.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Azienda Ospedaliero-Universitaria di Ferrara

Ferrara, 44124, Italy

RECRUITING

Policlinico Federico II

Napoli, Italy

RECRUITING

Ospedale "G.B. Grassi"

Roma, Italy

RECRUITING

Related Publications (5)

  • Ferrick AM, Raj SR, Deneke T, Kojodjojo P, Lopez-Cabanillas N, Abe H, Boveda S, Chew DS, Choi JI, Dagres N, Dalal AS, Dechert BE, Frazier-Mills CG, Gilbert O, Han JK, Hewit S, Kneeland C, DeEllen Mirza S, Mittal S, Ricci RP, Runte M, Sinclair S, Alkmim-Teixeira R, Vandenberk B, Varma N. 2023 HRS/EHRA/APHRS/LAHRS expert consensus statement on practical management of the remote device clinic. Heart Rhythm. 2023 Sep;20(9):e92-e144. doi: 10.1016/j.hrthm.2023.03.1525. Epub 2023 May 19.

    PMID: 37211145BACKGROUND
  • Glikson M, Nielsen JC, Kronborg MB, Michowitz Y, Auricchio A, Barbash IM, Barrabes JA, Boriani G, Braunschweig F, Brignole M, Burri H, Coats AJS, Deharo JC, Delgado V, Diller GP, Israel CW, Keren A, Knops RE, Kotecha D, Leclercq C, Merkely B, Starck C, Thylen I, Tolosana JM; ESC Scientific Document Group. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2021 Sep 14;42(35):3427-3520. doi: 10.1093/eurheartj/ehab364. No abstract available.

    PMID: 34455430BACKGROUND
  • Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA, Charron P, Corrado D, Dagres N, de Chillou C, Eckardt L, Friede T, Haugaa KH, Hocini M, Lambiase PD, Marijon E, Merino JL, Peichl P, Priori SG, Reichlin T, Schulz-Menger J, Sticherling C, Tzeis S, Verstrael A, Volterrani M; ESC Scientific Document Group. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022 Oct 21;43(40):3997-4126. doi: 10.1093/eurheartj/ehac262. No abstract available.

    PMID: 36017572BACKGROUND
  • Maines M, Tomasi G, Moggio P, Peruzza F, Catanzariti D, Angheben C, Simoncelli M, Degiampietro M, Piffer L, Valsecchi S, Del Greco M. Implementation of remote follow-up of cardiac implantable electronic devices in clinical practice: organizational implications and resource consumption. J Cardiovasc Med (Hagerstown). 2020 Sep;21(9):648-653. doi: 10.2459/JCM.0000000000001011.

    PMID: 32628426BACKGROUND
  • Palmisano P, Melissano D, Zanotto G, Perego GB, Toselli T, Landolina M, Ricci RP; Italian Association of Arrhythmology, Cardiac Pacing (AIAC). Change in the use of remote monitoring of cardiac implantable electronic devices in Italian clinical practice over a 5-year period: results of two surveys promoted by the AIAC (Italian Association of Arrhythmology and Cardiac Pacing). J Cardiovasc Med (Hagerstown). 2020 Apr;21(4):305-314. doi: 10.2459/JCM.0000000000000950.

    PMID: 32073430BACKGROUND

MeSH Terms

Conditions

Cardiovascular DiseasesArrhythmias, CardiacHeart FailureDeath, Sudden, Cardiac

Condition Hierarchy (Ancestors)

Heart DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsHeart ArrestDeath, SuddenDeath

Study Officials

  • Matteo Bertini, Prof

    Azienda Ospedaliera Universitaria di Ferrara

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Matteo Bertini, Prof

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
10 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 7, 2024

First Posted

March 15, 2024

Study Start

December 1, 2023

Primary Completion (Estimated)

December 31, 2043

Study Completion (Estimated)

December 31, 2043

Last Updated

August 12, 2024

Record last verified: 2023-12

Locations